IDEX Biometrics ASA: Mandatory notification of subscription by primary insider – 2 Dec 2024

GlobeNewswire
2024-12-02

Reference is made to the subsequent offering in IDEX Biometrics ASA (the “Company”) approved by the Extraordinary General Meeting on 9 October 2024.

The Company’s Chair, Morten Opstad, has subscribed to 1,000,000 shares, at NOK 0.15 per share. Whereof he subscribed to 250,000 shares for K-Konsult AS, and 750,000 shares for Marc O Polo Norge AS. The final allocation, including the primary insider registration form, will be notified later today.

For further information contact:
Marianne Bøe, Head of Investor Relations
Kristian Flaten, CFO
E-mail: ir@idexbiometrics.com
Tel: + 47 67 83 91 19



About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

For more information, visit www.idexbiometrics.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

This notice was issued by Marianne Bøe, Head of Investor Relations, on 2 December November 2024 at 08:55 CET on behalf of IDEX Biometrics ASA.


免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10